<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04846244</url>
  </required_header>
  <id_info>
    <org_study_id>P20-410</org_study_id>
    <nct_id>NCT04846244</nct_id>
  </id_info>
  <brief_title>A Study of the Change in Early and Sustained Pain Control in Radiographic Axial Spondylarthritis in Adult Participants Receiving Upadacitinib</brief_title>
  <acronym>UPSTAND</acronym>
  <official_title>Real World Effectiveness of Upadacitinib on Early and Sustained Pain Control in Radiographic Axial Spondylarthritis (UPSTAND)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AbbVie</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AbbVie</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Axial spondyloarthritis (axSpA) is an immune-mediated inflammatory disease primarily&#xD;
      affecting the axial skeleton. The most frequent axSpA symptom is chronic, often inflammatory&#xD;
      back pain (IBP) that might be difficult to distinguish from other causes of chronic back pain&#xD;
      (CBP). Many participants report persistent pain, including back pain, which impacts disease&#xD;
      activity and quality of life including creating burdens such as sleep disturbance, social&#xD;
      isolation, loss of productivity, as well as anxiety and depression. Despite this, there is a&#xD;
      lack of detailed data and knowledge on pain in radiographic-axial spondyloarthritis&#xD;
      (r-axSpA), including pain types, how it is localized, and how these different facets of pain&#xD;
      are impacted by treatment. This study will assess the real-world effectiveness of&#xD;
      upadacitinib on early and sustained pain control, and the association between pain and&#xD;
      clinical/patient-reported outcomes in radiographic axSpA participants.&#xD;
&#xD;
      Upadacitinib is being developed for the treatment of r-axSpA. Approximately 877 adult&#xD;
      participants with activer-axSpA will be enrolled across approximately 19 countries in Europe,&#xD;
      North America, South America, and Asia-Pacific.&#xD;
&#xD;
      Participants will receive oral upadacitinib tablets as prescribed by the physician prior to&#xD;
      enrolling in this study in accordance with the terms of the local marketing authorization and&#xD;
      professional and reimbursement guidelines with regards to dose, population and indication.&#xD;
      The overall duration of the study is approximately 30 months.&#xD;
&#xD;
      There may be a higher burden for participants in this study compared to usual standard of&#xD;
      care. Participants will attend regular visits per routine clinical practice. The effect of&#xD;
      the treatment will be checked by medical assessments, checking for side effects, and&#xD;
      questionnaires.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 30, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Participants with a Total Spinal Pain Score &lt; 4 and &gt;= 2 Unit (0 - 10) Improvement</measure>
    <time_frame>Baseline (Week 0) to Week 12</time_frame>
    <description>Total spinal pain consists of the mean of two 0-10 numerical rating scale (NRS) questions: total back pain during the previous week and nocturnal back pain during the previous week.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Participants Maintaining Total Spinal Pain &lt; 4 Among Participants Who Achieved Total Spinal Pain &lt; 4 and &gt;= 2 unit (0 - 10) Improvement from Baseline at Week 12</measure>
    <time_frame>Week 52</time_frame>
    <description>Total spinal pain score consists of the mean of two 0-10 NRS questions: total back pain during the previous week and nocturnal back pain during the previous week.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Participant's Assessment of Total Spinal Pain</measure>
    <time_frame>Baseline to Week 52</time_frame>
    <description>Total spinal pain consists of the mean of two 0-10 NRS questions: total back pain during the previous week and nocturnal back pain during the previous week.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Patient's Assessment of Total Back Pain NRS</measure>
    <time_frame>Baseline (Week 0) to Week 52</time_frame>
    <description>Pain will be measured using a 0 - 10 numerical rating scale (NRS) for total back pain (0 = no pain and 10 = most severe pain).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Patient's Assessment of Nocturnal Back Pain NRS</measure>
    <time_frame>Baseline (Week 0) to Week 52</time_frame>
    <description>Pain will be measured using a 0 - 10 numerical rating scale (NRS) for nocturnal back pain (0 = no pain and 10 = most severe pain).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in painDETECT Questionnaire (PD-Q) Score</measure>
    <time_frame>Baseline (Week 0) to Week 52</time_frame>
    <description>The PD-Q is a patient-based questionnaire used to determine the prevalence of neuropathic pain components in low back pain participants. Scores range from -1 to 38, with higher scores indicating a greater likelihood of the participant's pain having a neuropathic component.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Widespread Pain Index (WPI)</measure>
    <time_frame>Baseline (Week 0) to Week 52</time_frame>
    <description>The WPI quantifies the extent of bodily pain on a 0 to 19 scale by asking participants if they have had pain or tenderness in 19 different body regions (shoulder girdle, hip, jaw, upper arm, upper leg, lower arm, and lower leg on each side of the body, as well as upper back, lower back, chest, neck, and abdomen) over the past week, with each painful or tender region scoring 1 point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Achieving Pittsburgh Sleep Quality Index (PSQI) score &lt; 5</measure>
    <time_frame>Up to Week 52</time_frame>
    <description>The PSQI consists of 19 individual items across 7 components: sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medications, and daytime dysfunction. Each component is scored from 0 (no difficulty) to 3 (severe difficulty) and summed to produce a total global score (range 0 to 21). A score of less than 5 is indicative of no clinical sleep impairment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Achieving Ankylosing Spondylitis Disease Activity Score Low Disease Activity .[ASDAS LDA (&lt; 2.1)]</measure>
    <time_frame>Up to Week 52</time_frame>
    <description>The ASDAS combines the following 5 disease activity variables: back pain (BASDAI Question 2 NRS score 0 - 10), peripheral pain/swelling (BASDAI Question 3 NRS score 0 - 10), duration of morning stiffness (BASDAI Question 6 NRS score 0 - 10), PtGA, and high-sensitivity c reactive protein (hsCRP) or erythrocyte sedimentation rate (ESR). Low disease is defined as an ASDAS &lt; 2.1.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Achieving Ankylosing Spondylitis Disease Activity Score Inactive Disease [ASDAS ID (&lt;1.3)]</measure>
    <time_frame>Up to Week 52</time_frame>
    <description>The ASDAS combines the following 5 disease activity variables: back pain (BASDAI Question 2 NRS score 0 - 10), peripheral pain/swelling (BASDAI Question 3 NRS score 0 - 10), duration of morning stiffness (BASDAI Question 6 NRS score 0 - 10), PtGA, and high-sensitivity c reactive protein (hsCRP) or erythrocyte sedimentation rate (ESR). Inactive disease is defined as an ASDAS &lt; 1.3.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)</measure>
    <time_frame>Baseline (Week 0) to Week 52</time_frame>
    <description>The BASDAI consists of 6 questions on a 0 to 10 NRS (0 being no problem and 10 being very severe problems) pertaining to the 5 major symptoms of r-axSpA: fatigue, spinal pain, peripheral joint pain/swelling, areas of localized tenderness (also called enthesitis, or inflammation of tendons and ligaments), morning stiffness duration, and morning stiffness severity. The overall BASDAI score ranges from 0 to 10, with higher scores indicating greater disease activity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in 12-Item Short Form Health Survey (SF-12) Physical Component Summary (PCS)</measure>
    <time_frame>Baseline (Week 0) to Week 52</time_frame>
    <description>The SF-12 is a generic health-related QoL instrument consisting of a subset of 12 questions from the 36-Item Short Form Health Survey (SF-36). It assesses quality of life (QoL) across 8 domains: physical functioning, role physical, role emotional, social functioning, bodily pain, vitality, mental health, and general health. The SF-12 is used to derive the PCS with higher scores indicating a higher QoL.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in 12-Item Short Form Health Survey (SF-12) Mental Component Summary (MCS)</measure>
    <time_frame>Baseline (Week 0) to Week 52</time_frame>
    <description>The SF-12 is a generic health-related QoL instrument consisting of a subset of 12 questions from the 36-Item Short Form Health Survey (SF-36). It assesses quality of life (QoL) across 8 domains: physical functioning, role physical, role emotional, social functioning, bodily pain, vitality, mental health, and general health. The SF-12 is used to derive the MCS with higher scores indicating a higher QoL.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Achieving [Hospital Anxiety and Depression Scale (HADS) score &lt;= 7] for a participants with HADS score &gt; 7 at Baseline</measure>
    <time_frame>Up to Week 52</time_frame>
    <description>The HADS assesses participant mental health status (consists of anxiety [Hospital Anxiety and Depression Scale-Anxiety (HADS-A)] and depression [Hospital Anxiety and Depression Scale-Depression (HADS-D)] subscales). The range for both subscales is 0 - 21, with 0 - 7 = normal, 8 - 10 = borderline abnormal, and 11 - 21 = abnormal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Bath Ankylosing Spondylitis Functional Index (BASFI)</measure>
    <time_frame>Baseline (Week 0) to Week 52</time_frame>
    <description>The BASFI is a validated patient-reported outcome (PRO) instrument for use in the r-axSpA participant population. It consists of 10 items measured on a 0 to 10 NRS, which assesses the ability to perform activities known to be problematic to r-axSpA patients such as dressing, bending, reaching, turning, and climbing steps. The total scores range from 0 to 10 with higher scores indicating worse physical functioning in r-axSpA participants.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in ASDAS</measure>
    <time_frame>Baseline (Week 0) to Week 52</time_frame>
    <description>The ASDAS combines the following 5 disease activity variables: back pain (BASDAI Question 2 NRS score 0 - 10), peripheral pain/swelling (BASDAI Question 3 NRS score 0 - 10), duration of morning stiffness (BASDAI Question 6 NRS score 0 - 10), PtGA, and high-sensitivity c reactive protein (hsCRP) or erythrocyte sedimentation rate (ESR).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in C-Reactive Protein (CRP)</measure>
    <time_frame>Baseline (Week 0) to Week 52</time_frame>
    <description>Change in CRP.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants with Discontinuation of Nonsteroidal Anti-Inflammatory Drug (NSAID) Among Participants using NSAIDs at Baseline</measure>
    <time_frame>Up to Week 52</time_frame>
    <description>Discontinuation of NSAID among participants using NSAIDs at Baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants using NSAIDs as Needed or Continuously</measure>
    <time_frame>Baseline (Week 0) to Week 52</time_frame>
    <description>Percentage of participants using NSAIDs as needed or continuously.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Total Daily Dose of NSAIDs</measure>
    <time_frame>Baseline (Week 0) to Week 52</time_frame>
    <description>Change in total daily dose of NSAIDs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Achieving Enthesitis Resolution [Maastricht Ankylosing Spondylitis Enthesitis Score (MASES = 0)] among Participants with any Enthesitis (MASES ≥ 1) at Baseline</measure>
    <time_frame>Baseline (Week 0) to Week 52</time_frame>
    <description>The MASES evaluates the presence or absence of enthesitis at 13 different sites (first costochondral joint left/right, seventh costochondral joint left/right, posterior superior iliac spine left/right, anterior superior iliac spine left/right, iliac crest left/right, fifth lumbar spinous process, and proximal insertion of Achilles tendon left/right).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants with New Onset of Extra-articular Manifestations (EAMs) Among Participants with no History of EAMs</measure>
    <time_frame>Up to Week 52</time_frame>
    <description>Percentage of participants with new onset for participants with no history of EAMs (e.g., uveitis and inflammatory bowel disease [IBD]).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants with Recurrence of EAMs among Participants with Previous History of EAMs</measure>
    <time_frame>Up to Week 52</time_frame>
    <description>Percentage of participants with recurrence for participants with previous history of EAMs (e.g., uveitis and IBD).</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">877</enrollment>
  <condition>Radiographic Axial Spondylarthritis (r-axSpA)</condition>
  <arm_group>
    <arm_group_label>Participants Receiving Upadacitinib</arm_group_label>
    <description>Participants receiving Upadacitinib for radiographic axial spondyloarthritis (r-axSpA).</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adult participants with Radiographic Axial Spondylarthritis (r-axSpA) who have been&#xD;
        prescribed upadacitinib in the course of routine practice according to relevant approved&#xD;
        licenses.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical diagnosis of Radiographic Axial Spondylarthritis (r-axSpA) and meeting the&#xD;
             modified New York Criteria for r-axSpA.&#xD;
&#xD;
          -  Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score ≥ 4 at Baseline.&#xD;
&#xD;
          -  Total back pain score ≥ 4 at Baseline.&#xD;
&#xD;
          -  Inadequate response to at least two nonsteroidal anti-inflammatory drugs (NSAIDs) over&#xD;
             an at least 4-week period in total at maximum recommended or tolerated doses, or&#xD;
             participant has an intolerance to contraindication for NSAIDs as defined by the&#xD;
             investigator.&#xD;
&#xD;
          -  Upadacitinib prescribed in accordance with the applicable approved label and local&#xD;
             regulatory and reimbursement policies.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prior exposure to any Janus kinase (JAK) inhibitor.&#xD;
&#xD;
          -  Participants demonstrating active symptoms of fibromyalgia as per clinical diagnosis.&#xD;
&#xD;
          -  Participation in a clinical trial of an investigational drug, concurrently or within&#xD;
             the last 30 days.&#xD;
&#xD;
          -  Unwillingness or inability to comply with the study requirements, including completion&#xD;
             of patient reported outcome questionnaires.&#xD;
&#xD;
          -  Participants who cannot be treated with upadacitinib according to the applicable&#xD;
             approved label (e.g., contraindications).&#xD;
&#xD;
          -  Vulnerable or protected adult patients with lack of capability to give informed&#xD;
             consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ABBVIE INC.</last_name>
    <role>Study Director</role>
    <affiliation>AbbVie</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ABBVIE CALL CENTER</last_name>
    <phone>844-663-3742</phone>
    <email>abbvieclinicaltrials@abbvie.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Italiano La Plata /ID# 230779</name>
      <address>
        <city>La Plata</city>
        <state>Buenos Aires</state>
        <zip>1902</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CER Instituto Medico /ID# 230782</name>
      <address>
        <city>Quilmes</city>
        <state>Buenos Aires</state>
        <zip>1878</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Instituto CAICI /ID# 230781</name>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <zip>2000</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cimer /Id# 230780</name>
      <address>
        <city>San Miguel de Tucuman</city>
        <zip>4000</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Woden Dermatology /ID# 231460</name>
      <address>
        <city>Phillip</city>
        <state>Australian Capital Territory</state>
        <zip>2606</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Genesis Research Services /ID# 231593</name>
      <address>
        <city>Broadmeadow</city>
        <state>New South Wales</state>
        <zip>2292</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Campbelltown Hospital /ID# 231462</name>
      <address>
        <city>Campbelltown</city>
        <state>New South Wales</state>
        <zip>2560</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Royal Prince Alfred Hospital /ID# 232417</name>
      <address>
        <city>Camperdown</city>
        <state>New South Wales</state>
        <zip>2050</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>BJC Health /ID# 230066</name>
      <address>
        <city>Paramatta</city>
        <state>New South Wales</state>
        <zip>2150</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Barwon Rheumatology Services /ID# 230068</name>
      <address>
        <city>Geelong</city>
        <state>Victoria</state>
        <zip>3220</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Peninsula Rheumatology /ID# 240172</name>
      <address>
        <city>Langwarrin</city>
        <state>Victoria</state>
        <zip>3910</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Joint West Rheumatology /ID# 231461</name>
      <address>
        <city>Murdoch</city>
        <state>Western Australia</state>
        <zip>6150</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cliniques Universitaires de Bruxelles Hopital Erasme /ID# 238961</name>
      <address>
        <city>Brussels</city>
        <state>Bruxelles-Capitale</state>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Rhumaconsult SPRL /ID# 231439</name>
      <address>
        <city>Charleroi</city>
        <state>Hainaut</state>
        <zip>6000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Onze Lieve Vrouw Hospital /ID# 238963</name>
      <address>
        <city>Aalst</city>
        <zip>9300</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>AZ Sint-Jan Brugge /ID# 238964</name>
      <address>
        <city>Brugge</city>
        <zip>8000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU Brugmann /ID# 238962</name>
      <address>
        <city>Bruxelles</city>
        <zip>1020</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Reumacentrum /ID# 231437</name>
      <address>
        <city>Genk</city>
        <zip>3600</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>ReumaClinic /ID# 231438</name>
      <address>
        <city>Genk</city>
        <zip>3600</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire du Sart Tilman CHU de Liege /ID# 231440</name>
      <address>
        <city>Liege</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>AZ Damiaan /ID# 231441</name>
      <address>
        <city>Oostende</city>
        <zip>8400</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>AZ-Delta /ID# 238966</name>
      <address>
        <city>Roeselare</city>
        <zip>8800</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Groupe de Recherche en Maladies Osseuses Inc /ID# 241111</name>
      <address>
        <city>Sainte-foy</city>
        <state>Quebec</state>
        <zip>G1V 3M7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>HCL - Hôpital Lyon Sud /ID# 228819</name>
      <address>
        <city>Pierre Benite CEDEX</city>
        <state>Auvergne-Rhone-Alpes</state>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHR Orleans - Hopital de la Source /ID# 234258</name>
      <address>
        <city>Orleans CEDEX 2</city>
        <state>Centre-Val De Loire</state>
        <zip>45067</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU de Besancon - Jean Minjoz /ID# 230528</name>
      <address>
        <city>Besancon</city>
        <state>Doubs</state>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU Limoges - Dupuytren 1 /ID# 229094</name>
      <address>
        <city>Limoges CEDEX 1</city>
        <state>Franche-Comte</state>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU Toulouse - Hopital Purpan /ID# 228818</name>
      <address>
        <city>TOULOUSE Cedex 9</city>
        <state>Haute-Garonne</state>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU Montpellier - Hôpital Saint Eloi /ID# 228829</name>
      <address>
        <city>Montpellier Cedex 5</city>
        <state>Herault</state>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU Montpellier - Hôpital Saint Eloi /ID# 240980</name>
      <address>
        <city>Montpellier Cedex 5</city>
        <state>Herault</state>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU de SAINT ETIENNE - Hopital Nord /ID# 228836</name>
      <address>
        <city>St. Priest En Jarez</city>
        <state>Loire</state>
        <zip>42270</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU Nice -Hopital Pasteur /ID# 229088</name>
      <address>
        <city>Nice CEDEX 1</city>
        <state>Provence-Alpes-Cote-d Azur</state>
        <zip>06002</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CH du Pays d'AIX /ID# 229095</name>
      <address>
        <city>Aix En Provence Cedex 1</city>
        <zip>13616</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier d'Arras /ID# 228833</name>
      <address>
        <city>Arras</city>
        <zip>62022</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU Bordeaux - Hopital Pellegrin /ID# 230548</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Infirmerie Protestante /ID# 228794</name>
      <address>
        <city>Caluire Et Cuire</city>
        <zip>69300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHRU Tours - Hopital Trousseau /ID# 228824</name>
      <address>
        <city>Chambray Les Tours</city>
        <zip>37170</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>C. H. Sud Francilien /ID# 228826</name>
      <address>
        <city>Corbeil Essonnes</city>
        <zip>91106</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHD Vendée- La Roche-sur-Yon - Les Oudairies /ID# 230947</name>
      <address>
        <city>La Roche Sur Yon</city>
        <zip>85000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU Grenoble - Hopital Michallon /ID# 228792</name>
      <address>
        <city>La Tronche</city>
        <zip>38700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU Lille - Hôpital Roger Salengro /ID# 228820</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinique de la Sauvegarde /ID# 229087</name>
      <address>
        <city>Lyon</city>
        <zip>69009</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>AP-HM - Hopital Sainte Marguerite /ID# 241024</name>
      <address>
        <city>Marseille</city>
        <zip>13009</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cabinet de rhumatologie /ID# 229091</name>
      <address>
        <city>Mennecy</city>
        <zip>91540</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CH Princesse Grace /ID# 228796</name>
      <address>
        <city>Monaco</city>
        <zip>98000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>AP-HP - Hopital Saint-Antoine /ID# 228795</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>AP-HP - Hopital Cochin /ID# 229970</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Polyclinique Courlancy /ID# 229093</name>
      <address>
        <city>Reims</city>
        <zip>51100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU de Rennes - Hospital Sud /ID# 228842</name>
      <address>
        <city>Rennes CEDEX 2</city>
        <zip>35203</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hôpital Charles-Nicolle /ID# 229096</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hôpital d'instruction des armées Bégin /ID# 228793</name>
      <address>
        <city>Saint-Mandé cedex</city>
        <zip>94163</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CH Saint Nazaire /ID# 233186</name>
      <address>
        <city>St Nazaire</city>
        <zip>44600</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Chaim Sheba Medical Center /ID# 241305</name>
      <address>
        <city>Ramat Gan</city>
        <state>Tel-Aviv</state>
        <zip>5265601</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Tel Aviv Sourasky Medical Center /ID# 241864</name>
      <address>
        <city>Tel Aviv-Yafo</city>
        <state>Tel-Aviv</state>
        <zip>6423906</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Bnai Zion Medical Center /ID# 241866</name>
      <address>
        <city>Haifa</city>
        <zip>3339419</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hadassah Medical Center-Hebrew University /ID# 241865</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Adan Hospital /ID# 229679</name>
      <address>
        <city>Adan</city>
        <country>Kuwait</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Jahra Hospital /ID# 229671</name>
      <address>
        <city>Jahra</city>
        <zip>52700</zip>
        <country>Kuwait</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>ChUZ Clinical Hospital RZD-Medicine /ID# 233185</name>
      <address>
        <city>Ulan-Ude</city>
        <state>Buryatiya, Respublika</state>
        <zip>670002</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Regional Clinical Hospital of Kaliningrad region /ID# 238475</name>
      <address>
        <city>Kaliningrad</city>
        <state>Kaliningradskaya Oblast</state>
        <zip>236016</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>LLC MC RevmaMed /ID# 238478</name>
      <address>
        <city>Syktyvkar</city>
        <state>Komi, Respublika</state>
        <zip>167031</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Moscow Regional Research and Clinical Institute n.a. Vladimirskiy (MONIKI) /ID# 232510</name>
      <address>
        <city>Moscow</city>
        <state>Moskovskaya Oblast</state>
        <zip>129110</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Research Institute of Rheumatology named after V.A. Nasonova /ID# 238479</name>
      <address>
        <city>Moscow</city>
        <state>Moskva</state>
        <zip>115522</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Samara Regional Clinical Hospital n.a. V. D. Seredavin /ID# 231169</name>
      <address>
        <city>Samara</city>
        <state>Samarskaya Oblast</state>
        <zip>443095</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Nort-Western State Medical University n.a. Mechnikov /ID# 231172</name>
      <address>
        <city>St. Petersburg</city>
        <state>Sankt-Peterburg</state>
        <zip>193015</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>City Clinical Hospital #52 /ID# 238477</name>
      <address>
        <city>Moscow</city>
        <zip>123182</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Orenburg State Medical University /ID# 233183</name>
      <address>
        <city>Orenburg</city>
        <zip>460000</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Republican hospital named after V.A. Baranov /ID# 231173</name>
      <address>
        <city>Petrozavodsk</city>
        <zip>185019</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinical Rheumatologic Hospital No 25 /ID# 231171</name>
      <address>
        <city>St. Petersburg</city>
        <zip>190068</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Nebbiolo Clinical Research Center /ID# 231167</name>
      <address>
        <city>Tomsk</city>
        <zip>634009</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ulyanovsk Regional Clinical Hospital /ID# 238334</name>
      <address>
        <city>Ulyanovsk</city>
        <zip>432017</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Yaroslavl State Medicat University /ID# 231168</name>
      <address>
        <city>Yaroslavl</city>
        <zip>150000</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kantonsspital St. Gallen /ID# 230696</name>
      <address>
        <city>St. Gallen</city>
        <state>Sankt Gallen</state>
        <zip>9007</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Rheumatologisches Versorgungszentrum Weinfelden /ID# 239435</name>
      <address>
        <city>Weinfelden</city>
        <state>Thurgau</state>
        <zip>8570</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mediclinic Airport Road Hospital /ID# 231227</name>
      <address>
        <city>Abu Dhabi</city>
        <country>United Arab Emirates</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>AlAin Hospital /ID# 233803</name>
      <address>
        <city>Dubai</city>
        <country>United Arab Emirates</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mediclinic City Hospital /ID# 231226</name>
      <address>
        <city>Dubai</city>
        <country>United Arab Emirates</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medica Uruguaya /ID# 231078</name>
      <address>
        <city>Montevideo</city>
        <zip>11600</zip>
        <country>Uruguay</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>France</country>
    <country>Israel</country>
    <country>Kuwait</country>
    <country>Russian Federation</country>
    <country>Switzerland</country>
    <country>United Arab Emirates</country>
    <country>Uruguay</country>
  </location_countries>
  <link>
    <url>https://www.rxabbvie.com</url>
    <description>This clinical study may be evaluating a usage that is not currently FDA approved. Please see US Prescribing Information for approved uses.</description>
  </link>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>April 13, 2021</study_first_submitted>
  <study_first_submitted_qc>April 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 15, 2021</study_first_posted>
  <last_update_submitted>November 16, 2021</last_update_submitted>
  <last_update_submitted_qc>November 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Radiographic Axial Spondylarthritis (r-axSpA)</keyword>
  <keyword>Upadacitinib</keyword>
  <keyword>RINVOQ</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spondylarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

